Stelac Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,001
Closed -$130K 121
2019
Q4
$130K Hold
2,001
0.09% 77
2019
Q3
$127K Hold
2,001
0.09% 95
2019
Q2
$135K Sell
2,001
-381
-16% -$25.1K 0.1% 71
2019
Q1
$149K Hold
2,382
0.07% 73
2018
Q4
$149K Sell
2,382
-455
-16% -$31.8K 0.07% 67
2018
Q3
$219K Buy
2,837
+530
+23% +$40K 0.06% 73
2018
Q2
$163K Buy
2,307
+441
+24% +$31.1K 0.05% 95
2018
Q1
$141K Buy
+1,866
New +$148K 0.04% 96
2017
Q4
Sell
-10,707
Closed -$867K 78
2017
Q3
$867K Buy
10,707
+176
+2% +$13.5K 0.26% 33
2017
Q2
$745K Hold
10,531
0.25% 26
2017
Q1
$715K Buy
10,531
+2,558
+32% +$180K 0.22% 30
2016
Q4
$571K Buy
+7,973
New +$593K 0.19% 36

Other funds holding GILD

Stelac Advisory Services's GILD Position: Q1 2020 in Review

Stelac Advisory Services sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 2,001 shares — an estimated $130K sold.

Stelac Advisory Services first reported a position in GILD in Q4 2016 and held it in 12 quarters. The position peaked at $867K in Q3 2017. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Stelac Advisory Services reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Stelac Advisory Services sold 2,001 Gilead Sciences shares in Q1 2020, an estimated $130K.
  • Stelac Advisory Services first reported a position in Gilead Sciences in Q4 2016 and held it in 12 quarters.
  • Stelac Advisory Services's Gilead Sciences position peaked at $867K in Q3 2017.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Stelac Advisory Services's 13F filing for Q1 2020, filed 6 May 2020.